BLOG/πŸ‡ΊπŸ‡ΈUnited StatesΒ·Β·daily

Dow Jones 30 Stocks SEC Filings β€” January 08, 2026

USA Dow Jones 30

24 high priority30 medium priority54 total filings analysed

Executive Summary

On January 9, 2026, 54 8-K filings from predominantly small- and micro-cap firms (despite the Dow 30 stream focus) highlighted clusters of SPAC de-SPAC mergers, widespread leadership changes, multiple delistings, and auditor shifts, amid routine financial disclosures in biotechs. Bearish signals dominate via delistings (4 high-materiality cases) and accounting concerns, contrasting neutral M&A activity, indicating systemic distress in microcaps with dilution risks from unregistered equity sales. Institutional investors face elevated small-cap volatility; trim exposures to delisting-threatened names while eyeing post-merger SPAC alpha, as cumulative patterns suggest sector rotation away from compliant-challenged firms.

Tracking the trend? Catch up on the prior Dow Jones 30 Stocks SEC Filings digest from January 07, 2026.

Investment Signals(4)

  • β–²

    Multiple delistings signaling liquidity crises and compliance failures [BEARISH] - Onfolio Holdings, Advantage Solutions, TruGolf Holdings, Brag House Holdings

  • β–²

    Auditor changes hinting at financial reporting weaknesses [BEARISH] - Hills Bancorporation, Vishay Intertechnology, Safe & Green Holdings

  • β–²

    Non-reliance on prior financials indicating material accounting issues [BEARISH] - Southwest Gas Holdings

  • β–²

    SPAC de-SPAC completions with control changes offering potential value unlock [BULLISH] - Welsbach Technology Metals Acquisition, Silicon Valley Acquisition

Risk Flags(3)

  • β–Ό

    Cluster of 4 delistings (Item 3.01) across microcaps erodes liquidity and signals broad operational/financial distress

  • β–Ό

    3 auditor changes (Item 4.01) plus Item 4.02 non-reliance raise systemic accounting control risks

  • β–Ό

    Recurrent unregistered equity sales (Item 3.02 in 8+ filings) amplify portfolio dilution threats in small caps

Opportunities(3)

  • β—†

    SPAC mergers (Welsbach, Silicon Valley, La Rosa) with asset completions (Item 2.01) for post-deal catalysts and governance resets

  • β—†

    Biotech/pharma earnings wave (Immunocore, Perspective Therapeutics, NewAmsterdam) via Item 2.02 for sector momentum plays

  • β—†

    Leadership refreshes (15+ Item 5.02 filings) as entry points for stabilized governance in underfollowed names

Sector Themes(3)

  • β—†

    SPAC/M&A surge with 7+ filings on definitive agreements, asset completions, and control shifts signaling consolidation in acquisition vehicles

  • β—†

    Biotech/healthcare disclosure density (10+ firms with Reg FD, results) amid neutral sentiment, hinting at pipeline or trial updates

  • β—†

    Governance churn via 15+ officer/director changes (Item 5.02) cross-sector, potentially presaging strategic pivots or instability

Watch List(4)

  • πŸ‘

    Delisting cluster (Onfolio, Advantage Solutions, TruGolf, Brag House) - Monitor for sharp declines and OTC transfers

  • πŸ‘

    Auditor changers (Vishay, Safe & Green, Hills Bancorp) - Probe for disagreement disclosures or restatements

  • πŸ‘

    Welsbach Technology Metals (8-K and 8-K/A) - Track merger target reveal and dilution impacts

  • πŸ‘

    Southwest Gas Holdings - Assess Item 4.02 restatement scope for broader energy sector contagion

Filing Analyses(54)
SUI Group Holdings Ltd.8-Kneutralmateriality 2/10

09-01-2026

SUI Group Holdings Ltd. filed a Form 8-K on January 09, 2026 (AccNo: 0001654954-26-000201, Size: 202 KB), disclosing Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No details on the content of the Regulation FD disclosure or specific financial statements/exhibits are provided. Sector not specified.

SUI Group Holdings Ltd.8-Kneutralmateriality 3/10

09-01-2026

SUI Group Holdings Ltd. filed a Form 8-K on January 09, 2026 (AccNo: 0001654954-26-000203, Size: 170 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and other events under Item 8.01. No specific details on the affected officer, position, appointment/resignation, reasons, or quantitative data provided in the filing summary. Sector not specified.

Welsbach Technology Metals Acquisition Corp.8-Kneutralmateriality 8/10

09-01-2026

Welsbach Technology Metals Acquisition Corp. filed an 8-K on 2026-01-09 (AccNo: 0001213900-26-002600, Size: 5 MB) disclosing entry into a material definitive agreement (Item 1.01), completion of acquisition or disposition of assets (Item 2.01), creation of financial obligations (Item 2.03), unregistered equity sales (Item 3.02), modifications to security holder rights (Item 3.03), changes in control (Item 5.01), director/officer changes (Item 5.02), governance amendments (Item 5.03), and code of ethics amendments (Item 5.05). This indicates a significant merger/acquisition event likely involving a SPAC de-SPAC transaction, but target identity, deal terms, valuation, and financial details are NOT_DISCLOSED. Sector is not specified.

Silicon Valley Acquisition Corp.8-Kneutralmateriality 7/10

09-01-2026

Silicon Valley Acquisition Corp. filed an 8-K on January 9, 2026 (AccNo: 0001213900-26-002599, Size: 331 KB), disclosing entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), other events (Item 8.01), and financial statements and exhibits (Item 9.01). This filing relates to a Merger/Acquisition event in the US market, but no specific parties, deal structure, valuation, or quantitative details are disclosed. Sector is not specified.

RYVYL Inc.8-Kneutralmateriality 4/10

09-01-2026

RYVYL Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001185185-26-000081, Size: 26 MB), reporting unregistered sales of equity securities under Item 3.02 and financial statements and exhibits under Item 9.01. No details on transaction value, share count, or financial impacts are disclosed. This is a multi-item mandatory filing focused on equity securities compliance.

uniQure N.V.8-Kneutralmateriality 3/10

09-01-2026

uniQure N.V. filed a Form 8-K on January 9, 2026 (AccNo: 0001104659-26-002317), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No details on core events, transactions, financial impacts, or numerical values are explicitly stated in the provided filing summary. This appears to be a multi-item voluntary disclosure related to Regulation FD compliance.

Immunocore Holdings plc8-Kneutralmateriality 5/10

09-01-2026

Immunocore Holdings plc filed a Form 8-K on January 9, 2026 (AccNo: 0001140361-26-000780, size 9 MB), reporting Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing related to financial results. No specific financial metrics, transaction values, or other numerical data disclosed in the provided filing summary.

Aquestive Therapeutics, Inc.8-Kneutralmateriality 3/10

09-01-2026

Aquestive Therapeutics, Inc. filed a Form 8-K on January 09, 2026 (AccNo: 0001398733-26-000003, Size: 1 MB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the event, transaction, financial statements, or exhibits are provided in the filing summary. Sector is not specified.

Perspective Therapeutics, Inc.8-Kneutralmateriality 5/10

09-01-2026

Perspective Therapeutics, Inc. filed an 8-K on January 9, 2026 (AccNo: 0001193125-26-008277, Size: 274 KB) reporting under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, transaction details, or quantitative data are disclosed in the provided filing summary. Sector is not specified.

RYVYL Inc.8-Kneutralmateriality 3/10

09-01-2026

RYVYL Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001185185-26-000092, Size: 205 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific event, transaction, financial statements, or exhibits are disclosed in the provided filing summary. Sector not specified; all quantitative financial metrics NOT_DISCLOSED.

La Rosa Holdings Corp.8-Kneutralmateriality 8/10

09-01-2026

La Rosa Holdings Corp. filed a Form 8-K on January 9, 2026 (AccNo: 0001213900-26-002685, Size: 3 MB), reporting multiple material events including Entry into a Material Definitive Agreement (Item 1.01), Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement (Item 2.03), Unregistered Sales of Equity Securities (Item 3.02), Material Modifications to Rights of Security Holders (Item 3.03), and Amendments to Articles of Incorporation or Bylaws (Item 5.03), with Financial Statements and Exhibits under Item 9.01. This is a multi-item mandatory filing with no specific transaction details, dollar values, or quantitative impacts disclosed in the provided summary. Sector is not specified.

IOVANCE BIOTHERAPEUTICS, INC.8-Kneutralmateriality 3/10

09-01-2026

Iovance Biotherapeutics, Inc. filed a Form 8-K on January 09, 2026 (AccNo: 0001104659-26-002323, Size: 8 MB), reporting Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No details on the specific event, transaction, financial impacts, or other quantitative data are disclosed in the provided filing summary. Sector not specified.

NewAmsterdam Pharma Co N.V.8-Kneutralmateriality 5/10

09-01-2026

NewAmsterdam Pharma Co N.V. filed an 8-K on January 9, 2026 (AccNo: 0001193125-26-008300, Size: 269 KB), reporting under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a financial results disclosure for a company in an unspecified sector. No specific financial metrics, transaction values, or other quantitative details are provided in the filing summary.

Intellia Therapeutics, Inc.8-Kneutralmateriality 5/10

09-01-2026

Intellia Therapeutics, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001193125-26-008307, Size: 5 MB), reporting under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific details on events, transactions, financial impacts, or quantitative data are explicitly stated in the provided filing summary. This is a multi-item voluntary or mandatory disclosure depending on the underlying events, but core event details are NOT_DISCLOSED.

Savara Inc8-Kneutralmateriality 3/10

09-01-2026

Savara Inc filed a Form 8-K on January 09, 2026 (AccNo: 0001193125-26-008301, size: 6 MB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No core event, transaction details, financial metrics, or other specifics are disclosed in the provided filing summary. This is a general filing from the US SEC with sector not specified.

Koppers Holdings Inc.8-Kneutralmateriality 3/10

09-01-2026

Koppers Holdings Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001315257-26-000004, Size: 342 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements). The filing also includes Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer, position, reason, or quantitative data provided in the summary; sector not specified.

Aptevo Therapeutics Inc.8-Kneutralmateriality 5/10

09-01-2026

Aptevo Therapeutics Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001193125-26-008318, size: 700 KB), reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 3.02 (Unregistered Sales of Equity Securities), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the agreement, equity sales, events, or quantitative data provided in the summary. Sector not specified.

Ondas Holdings Inc.8-Kneutralmateriality 3/10

09-01-2026

Ondas Holdings Inc. filed a Form 8-K on January 09, 2026 (AccNo: 0001213900-26-002694, Size: 200 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the content of the disclosure, events, transactions, financial statements, or exhibits are provided in the filing summary. Sector is not specified.

Evolus, Inc.8-Kneutralmateriality 5/10

09-01-2026

Evolus, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001570562-26-000003, Size: 201 KB), reporting under Item 2.02 for Results of Operations and Financial Condition and Item 9.01 for Financial Statements and Exhibits. This constitutes a multi-item voluntary disclosure of financial results. No specific revenue, earnings, transaction values, or other quantitative financial metrics are disclosed in the provided filing summary.

Onfolio Holdings, Inc8-Kbearishmateriality 10/10

09-01-2026

Onfolio Holdings, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001654954-26-000212, Size: 165 KB) disclosing under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, including transfer of listing. No specific reasons, financial details, transaction values, or quantitative impacts are provided in the available information. Sector is not specified.

Vistra Corp.8-Kneutralmateriality 3/10

09-01-2026

Vistra Corp. filed a Form 8-K on January 9, 2026 (AccNo: 0001193125-26-008508, Size: 147 KB) under Item 7.01 for Regulation FD Disclosure. No specific details on events, transactions, financial impacts, or other quantitative data are disclosed in the provided filing summary. Sector is not specified.

Origin Bancorp, Inc.8-Kneutralmateriality 3/10

09-01-2026

Origin Bancorp, Inc. filed a Form 8-K on January 09, 2026 (AccNo: 0001516912-26-000004, Size: 222 KB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This appears to be a voluntary disclosure of material information, potentially including attached financial statements or exhibits. No core event details, transaction values, financial metrics, or other quantitative data are disclosed in the provided filing summary.

HILLS BANCORPORATION8-Kneutralmateriality 6/10

09-01-2026

HILLS BANCORPORATION filed a Form 8-K on January 9, 2026 (AccNo: 0000732417-26-000003), reporting under Item 4.01 a change in its certifying accountant. No details on the former or new auditor, reasons for change, financial impacts, or other quantitative data are disclosed in the provided filing summary. This is a single-item mandatory disclosure for a material event.

HONG YUAN HOLDING GROUP8-Kneutralmateriality 3/10

09-01-2026

Hong Yuan Holding Group filed a Form 8-K on January 9, 2026 (AccNo: 0001493152-26-001059, Size: 203 KB) disclosing an officer change under Item 5.02. Item 5.02 covers Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. No specific details on positions affected, individuals involved, reasons, or nature of change (appointment or departure) are stated.

KOPIN CORP8-Kneutralmateriality 4/10

09-01-2026

Kopin Corp filed a Form 8-K on January 9, 2026 (AccNo: 0001493152-26-001064, size 199 KB), disclosing an event under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as names, positions, reasons, or terms are provided. Sector not specified.

Venu Holding Corp8-Kneutralmateriality 8/10

09-01-2026

Venu Holding Corp filed a Form 8-K on January 09, 2026 (AccNo: 0001493152-26-001075, Size: 2 MB), reporting entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), amendments to articles of incorporation or bylaws or change in fiscal year (Item 5.03), and financial statements and exhibits (Item 9.01). This is a multi-item mandatory filing with no specific transaction details, dollar values, parties, or financial metrics disclosed in the provided summary. Sector not specified.

ECB Bancorp, Inc. /MD/8-Kneutralmateriality 2/10

09-01-2026

ECB Bancorp, Inc. /MD/ filed a Form 8-K on January 09, 2026 (AccNo: 0001437749-26-000982, Size: 168 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the event, transaction, financial statements, or exhibits are provided in the filing summary. Sector not specified.

Advantage Solutions Inc.8-Kbearishmateriality 10/10

09-01-2026

Advantage Solutions Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001193125-26-008903, Size: 254 KB), reporting Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. No additional details on delisting reasons, financial impacts, transaction values, or sector are disclosed. This indicates a delisting event from the US market.

MSP Recovery, Inc.8-Kneutralmateriality 7/10

09-01-2026

MSP Recovery, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001193125-26-008897, size 1 MB), reporting under Item 1.01 entry into a material definitive agreement, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, Item 2.04 triggering events accelerating or increasing such obligations, and Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific transaction details, dollar values, or financial metrics disclosed in the provided information. Sector not specified.

LiveWire Group, Inc.8-Kneutralmateriality 4/10

09-01-2026

LiveWire Group, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001898795-26-000008, Size: 174 KB) disclosing an event under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Specific details such as the key position affected, individual names, appointment or resignation status, reasons, or any quantitative data are NOT_DISCLOSED in the provided information. Sector is not specified.

BANK OF THE JAMES FINANCIAL GROUP INC8-Kneutralmateriality 2/10

09-01-2026

BANK OF THE JAMES FINANCIAL GROUP INC filed a Form 8-K on January 09, 2026 (AccNo: 0001275101-26-000002, Size: 193 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). Item 9.01 references Financial Statements and Exhibits. No specific details on the officer, position, reason, or quantitative data provided in the filing summary.

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.8-Kneutralmateriality 2/10

09-01-2026

Charles River Laboratories International, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001628280-26-001603, Size: 142 KB) disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the affected position, individual involved, nature of change (appointment or resignation), reasons, or compensation are provided. Sector not specified.

Thryv Holdings, Inc.8-Kneutralmateriality 3/10

09-01-2026

Thryv Holdings, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001140361-26-000830, Size: 322 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). Item 9.01 references Financial Statements and Exhibits. No specific details on the officer position, appointment/resignation, reasons, or quantitative data are provided.

CF Industries Holdings, Inc.8-Kneutralmateriality 1/10

09-01-2026

CF Industries Holdings, Inc. filed a Form 8-K on January 09, 2026, under Item 8.01 Other Events. Accession Number: 0001104659-26-002476. File size: 187 KB; no specific event details, transaction values, or financial metrics disclosed.

VISHAY INTERTECHNOLOGY INC8-Kneutralmateriality 7/10

09-01-2026

Vishay Intertechnology Inc filed a Form 8-K on January 9, 2026 (AccNo: 0000103730-26-000003, size 168 KB), reporting changes in its certifying accountant under Item 4.01. Item 9.01 discloses financial statements and exhibits. No additional details on the change, reasons, new accountant, or exhibits are provided.

Inflection Point Acquisition Corp. V8-Kneutralmateriality 4/10

09-01-2026

Inflection Point Acquisition Corp. V filed an 8-K on January 9, 2026 (AccNo: 0001213900-26-002931, Size: 280 KB) disclosing entry into a Material Definitive Agreement (Item 1.01), creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement (Item 2.03), and Financial Statements and Exhibits (Item 9.01). This pertains to a Merger/Acquisition event in an unspecified sector. No specific details on parties, structure, valuation, or terms are disclosed in the provided filing summary.

Microvast Holdings, Inc.8-Kneutralmateriality 3/10

09-01-2026

Microvast Holdings, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0000947871-26-000019, Size: 276 KB) disclosing an event under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 lists financial statements and exhibits. No specific details on the officer involved, position affected, nature of change (appointment/resignation), reasons, or any quantitative data are provided in the filing summary.

PEDEVCO CORP8-Kneutralmateriality 5/10

09-01-2026

PEDEVCO CORP filed a Form 8-K on January 09, 2026 (AccNo: 0001654954-26-000231, Size: 151 KB), reporting under Item 2.03 the creation of a direct financial obligation or off-balance sheet arrangement, and under Item 5.07 the submission of matters to a vote of security holders. No specific details on the nature, size, or terms of the financial obligation or the shareholder vote matters are disclosed in the provided filing summary. Sector is not specified.

Boot Barn Holdings, Inc.8-Kneutralmateriality 7/10

09-01-2026

Boot Barn Holdings, Inc. filed a Form 8-K on January 09, 2026 (AccNo: 0001104659-26-002514, Size: 4 MB), disclosing under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This multi-item filing reports financial results. No specific revenue, earnings, transaction values, or other quantitative metrics are mentioned.

TruGolf Holdings, Inc.8-Kbearishmateriality 10/10

09-01-2026

TruGolf Holdings, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001493152-26-001110, Size: 200 KB) reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. No specific details on the core event, reasons for delisting, financial impacts, transaction values, or other quantitative data are disclosed. Sector is not specified.

STEVEN MADDEN, LTD.8-Kneutralmateriality 2/10

09-01-2026

Steven Madden, Ltd. filed a Form 8-K on January 9, 2026 (AccNo: 0001493152-26-001108), disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements. Item 9.01 indicates financial statements and exhibits are included. No specific details on the officer, position, reason, or terms are provided in the filing summary.

Abacus Global Management, Inc.8-Kneutralmateriality 4/10

09-01-2026

Abacus Global Management, Inc. filed a Form 8-K on January 09, 2026 (AccNo: 0001628280-26-001644, Size: 1 MB), reporting Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No core event details, transaction values, financial metrics, or other quantitative data are disclosed. This appears to be a multi-item voluntary disclosure under Regulation FD.

BED BATH & BEYOND, INC.8-Kneutralmateriality 3/10

09-01-2026

BED BATH & BEYOND, INC. filed a Form 8-K on January 09, 2026 (AccNo: 0001140361-26-000846, Size: 195 KB), reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the events, transactions, financial statements, or exhibits are disclosed in the provided filing summary. Sector is not specified.

NOVAGOLD RESOURCES INC8-Kneutralmateriality 5/10

09-01-2026

NOVAGOLD RESOURCES INC filed a Form 8-K on January 9, 2026 (AccNo: 0001171843-26-000168, size 248 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No core event, transaction details, financial metrics, or other specifics are disclosed in the provided filing summary. This is a multi-item voluntary disclosure focused on Reg FD material information and attached exhibits.

Vicarious Surgical Inc.8-Kneutralmateriality 2/10

09-01-2026

Vicarious Surgical Inc. filed a Form 8-K on January 09, 2026 (AccNo: 0001213900-26-002973, Size: 190 KB), reporting Item 5.07: Submission of Matters to a Vote of Security Holders. This is a single-item filing disclosing shareholder vote results. No specific vote outcomes, proposals, numbers, or other details are provided.

Southwest Gas Holdings, Inc.8-Kbearishmateriality 8/10

09-01-2026

Southwest Gas Holdings, Inc. filed an 8-K on January 09, 2026 (AccNo: 0001692115-26-000004), disclosing Items 2.02 (Results of Operations and Financial Condition), 4.02 (Non-Reliance on Previously Issued Financial Statements or Related Audit Report), and 7.01 (Regulation FD Disclosure). No specific financial metrics, transaction values, or quantitative data are provided in the filing summary. This multi-item filing signals potential accounting issues alongside operational results.

SAFE & GREEN HOLDINGS CORP.8-Kbearishmateriality 8/10

09-01-2026

SAFE & GREEN HOLDINGS CORP. filed a Form 8-K on January 9, 2026 (AccNo: 0001213900-26-002999, Size: 234 KB), reporting a change in its certifying accountant under Item 4.01 and attaching financial statements and exhibits under Item 9.01. No details on the former or new accountant, reasons for the change, financial impacts, or other specifics are disclosed in the provided filing summary. This is a multi-item mandatory disclosure event.

Sun Country Airlines Holdings, Inc.8-Kneutralmateriality 3/10

09-01-2026

Sun Country Airlines Holdings, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001193125-26-009087, Size: 137 KB), disclosing an officer change under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the affected officer, position, appointment/resignation status, reasons, or any quantitative data are provided in the filing summary. Sector is not specified.

Bark, Inc.8-Kneutralmateriality 3/10

09-01-2026

Bark, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001628280-26-001646, Size: 215 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the event, transaction, financial statements, or exhibits are disclosed in the provided filing summary. Sector not specified.

FLYEXCLUSIVE INC.8-Kneutralmateriality 8/10

09-01-2026

FLYEXCLUSIVE INC. filed a Form 8-K on January 9, 2026 (AccNo: 0001193125-26-009100, Size: 986 KB), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the agreement, events, or exhibits provided in the available information. Sector is not specified.

Vistagen Therapeutics, Inc.8-Kneutralmateriality 3/10

09-01-2026

Vistagen Therapeutics, Inc. filed a Form 8-K on January 09, 2026 (AccNo: 0001628280-26-001690, size: 7 MB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No details on the specific content of the disclosure or exhibits are provided. Sector not specified.

Welsbach Technology Metals Acquisition Corp.8-K/Aneutralmateriality 0/10

09-01-2026

Welsbach Technology Metals Acquisition Corp. filed an 8-K on January 9, 2026 (AccNo: 0001213900-26-003038), disclosing entry into a material definitive agreement (Item 1.01), completion of an acquisition or disposition of assets (Item 2.01), creation of financial obligations (Item 2.03), unregistered sales of equity securities (Item 3.02), material modifications to security holder rights (Item 3.03), changes in control (Item 5.01), director/officer changes (Item 5.02), amendments to articles/bylaws (Item 5.03), and code of ethics amendments (Item 5.05). No specific details on deal structure, parties, valuation, or financial metrics are disclosed in the provided filing summary.

Enveric Biosciences, Inc.8-Kneutralmateriality 4/10

09-01-2026

Enveric Biosciences, Inc. filed a Form 8-K on January 09, 2026 (AccNo: 0001493152-26-001151, Size: 9 MB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item voluntary disclosure with no core event, transaction details, or quantitative financial data explicitly stated in the provided filing summary. Sector is not specified.

Brag House Holdings, Inc.8-Kbearishmateriality 9/10

09-01-2026

Brag House Holdings, Inc. filed a Form 8-K on January 9, 2026 (AccNo: 0001213900-26-003029, Size: 189 KB), reporting under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. No specific reasons for delisting, exchange involved, financial impacts, or transaction details are disclosed. Sector is not specified.

Get daily alerts with 4 investment signals, 3 risk alerts, 3 opportunities and full AI analysis of all 54 filings

πŸ‡ΊπŸ‡Έ More from United States

View all β†’
Dow Jones 30 Stocks SEC Filings β€” January 08, 2026 | Gunpowder Blog